Highland Capital Management (Tennessee)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,538
| Closed | -$831K | – | 418 |
|
|
2025
Q4 | $831K | Buy |
+2,538
| New | +$805K | 0.04% | 246 |
|
|
2024
Q4 | – | Sell |
-3,924
| Closed | -$1.26M | – | 378 |
|
|
2024
Q3 | $1.26M | Sell |
3,924
-2,478
| -39% | -$811K | 0.07% | 214 |
|
|
2024
Q2 | $2M | Sell |
6,402
-1,215
| -16% | -$357K | 0.12% | 162 |
|
|
2024
Q1 | $2.17M | Buy |
7,617
+9
| +0.1% | +$2.63K | 0.12% | 169 |
|
|
2023
Q4 | $2.19M | Sell |
7,608
-24
| -0.3% | -$6.54K | 0.14% | 167 |
|
|
2023
Q3 | $2.05M | Sell |
7,632
-140
| -2% | -$34.9K | 0.14% | 167 |
|
|
2023
Q2 | $1.73M | Sell |
7,772
-27
| -0.3% | -$6.26K | 0.11% | 180 |
|
|
2023
Q1 | $1.89M | Sell |
7,799
-1,183
| -13% | -$290K | 0.14% | 147 |
|
|
2022
Q4 | $2.36M | Buy |
8,982
+962
| +12% | +$258K | 0.17% | 151 |
|
|
2022
Q3 | $1.81M | Sell |
8,020
-104
| -1% | -$25.2K | 0.14% | 158 |
|
|
2022
Q2 | $1.98M | Buy |
8,124
+5
| +0.1% | +$1.23K | 0.14% | 164 |
|
|
2022
Q1 | $1.96M | Buy |
8,119
+32
| +0.4% | +$7.35K | 0.12% | 178 |
|
|
2021
Q4 | $1.82M | Sell |
8,087
-100
| -1% | -$21.1K | 0.1% | 198 |
|
|
2021
Q3 | $1.74M | Sell |
8,187
-712
| -8% | -$164K | 0.11% | 203 |
|
|
2021
Q2 | $2.17M | Sell |
8,899
-354
| -4% | -$87.1K | 0.13% | 171 |
|
|
2021
Q1 | $2.3M | Sell |
9,253
-715
| -7% | -$171K | 0.14% | 164 |
|
|
2020
Q4 | $2.29M | Sell |
9,968
-19,472
| -66% | -$4.49M | 0.15% | 164 |
|
|
2020
Q3 | $7.48M | Sell |
29,440
-837
| -3% | -$207K | 0.53% | 51 |
|
|
2020
Q2 | $7.14M | Buy |
30,277
+3,151
| +12% | +$719K | 0.56% | 46 |
|
|
2020
Q1 | $5.5M | Buy |
27,126
+6,343
| +31% | +$1.39M | 0.52% | 55 |
|
|
2019
Q4 | $5.01M | Sell |
20,783
-12,383
| -37% | -$2.73M | 0.35% | 81 |
|
|
2019
Q3 | $6.42M | Sell |
33,166
-11,861
| -26% | -$2.28M | 0.48% | 59 |
|
|
2019
Q2 | $8.3M | Buy |
45,027
+12,731
| +39% | +$2.28M | 0.62% | 42 |
|
|
2019
Q1 | $6.14M | Sell |
32,296
-622
| -2% | -$119K | 0.47% | 61 |
|
|
2018
Q4 | $6.41M | Sell |
32,918
-3,025
| -8% | -$590K | 0.54% | 48 |
|
|
2018
Q3 | $7.45M | Buy |
35,943
+8,486
| +31% | +$1.67M | 0.54% | 49 |
|
|
2018
Q2 | $5.07M | Buy |
27,457
+262
| +1% | +$46.3K | 0.39% | 73 |
|
|
2018
Q1 | $4.64M | Buy |
27,195
+131
| +0.5% | +$24K | 0.36% | 83 |
|
|
2017
Q4 | $4.71M | Sell |
27,064
-494
| -2% | -$87.4K | 0.36% | 91 |
|
|
2017
Q3 | $5.14M | Sell |
27,558
-6,333
| -19% | -$1.12M | 0.41% | 80 |
|
|
2017
Q2 | $5.84M | Buy |
33,891
+22,465
| +197% | +$3.65M | 0.47% | 66 |
|
|
2017
Q1 | $1.88M | Sell |
11,426
-2,331
| -17% | -$387K | 0.15% | 142 |
|
|
2016
Q4 | $2.01M | Sell |
13,757
-4,051
| -23% | -$610K | 0.17% | 141 |
|
|
2016
Q3 | $2.97M | Buy |
17,808
+80
| +0.5% | +$13.5K | 0.25% | 114 |
|
|
2016
Q2 | $2.7M | Sell |
17,728
-10
| -0.1% | -$1.55K | 0.23% | 117 |
|
|
2016
Q1 | $2.66M | Buy |
17,738
+367
| +2% | +$54.5K | 0.23% | 124 |
|
|
2015
Q4 | $2.82M | Buy |
17,371
+11,610
| +202% | +$1.82M | 0.23% | 130 |
|
|
2015
Q3 | $797K | Buy |
5,761
+4,273
| +287% | +$674K | 0.07% | 252 |
|
|
2015
Q2 | $228K | Hold |
1,488
| – | – | 0.02% | 308 |
|
|
2015
Q1 | $238K | Buy |
1,488
+175
| +13% | +$27.6K | 0.05% | 133 |
|
|
2014
Q4 | $209K | Buy |
+1,313
| New | +$205K | 0.04% | 155 |
|
Other funds holding AMGN
VCM
VPM
Highland Capital Management (Tennessee)'s AMGN Position: Q1 2026 in Review
Highland Capital Management (Tennessee) sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2,538 shares — an estimated $831K sold.
Highland Capital Management (Tennessee) first reported a position in AMGN in Q4 2014 and held it in 41 quarters. The position peaked at $8.3M in Q2 2019. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Highland Capital Management (Tennessee) reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Highland Capital Management (Tennessee) sold 2,538 Amgen shares in Q1 2026, an estimated $831K.
- Highland Capital Management (Tennessee) first reported a position in Amgen in Q4 2014 and held it in 41 quarters.
- Highland Capital Management (Tennessee)'s Amgen position peaked at $8.3M in Q2 2019.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2026, filed 13 Apr 2026.